This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miller, C L Articles by Kieff, E Search for Related Content PubMed PubMed Citation Articles by Miller, C L Articles by Kieff, E

Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes.

Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115.

ABSTRACT

LMP2A is expressed in latent Epstein-Barr virus (EBV) infection and interacts with LMP1 and members of the src tyrosine kinase family in the plasma membrane. Since tyrosine kinase mediate receptor-induced changes in intracellular free calcium, the effect of LMP2A on receptor-mediated intracellular calcium mobilization was evaluated by stably expressing LMP2A in an EBV-negative Burkitt tumor cell line (BJAB) or in LMP1-converted BJAB cells. LMP2A significantly blocked calcium mobilization following class II, CD19, or immunoglobulin M cross-linking. LMP2A effects were partially reversed in LMP1-converted cell lines. These results are compatible with LMP2A acting in latent B-lymphocyte infection to downmodulate LMP1 effects on cell growth or to inhibit induction of lytic EBV infection in specific human tissues following receptor ligation.

This article has been cited by other articles:

• Anderson, L. J., Longnecker, R. (2008). EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway. J. Gen. Virol. 89: 1563-1568 [Abstract] [Full Text]  
• Rechsteiner, M. P., Berger, C., Zauner, L., Sigrist, J. A., Weber, M., Longnecker, R., Bernasconi, M., Nadal, D. (2008). Latent Membrane Protein 2B Regulates Susceptibility to Induction of Lytic Epstein-Barr Virus Infection. J. Virol. 82: 1739-1747 [Abstract] [Full Text]  
• Mancao, C., Hammerschmidt, W. (2007). Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. Blood 110: 3715-3721 [Abstract] [Full Text]  
• Rovedo, M., Longnecker, R. (2007). Epstein-Barr Virus Latent Membrane Protein 2B (LMP2B) Modulates LMP2A Activity. J. Virol. 81: 84-94 [Abstract] [Full Text]  
• Wang, H., Nicholas, M. W., Conway, K. L., Sen, P., Diz, R., Tisch, R. M., Clarke, S. H. (2006). EBV Latent Membrane Protein 2A Induces Autoreactive B Cell Activation and TLR Hypersensitivity.. J. Immunol. 177: 2793-2802 [Abstract] [Full Text]  
• Swanson-Mungerson, M., Bultema, R., Longnecker, R. (2006). Epstein-Barr Virus LMP2A Enhances B-Cell Responses In Vivo and In Vitro. J. Virol. 80: 6764-6770 [Abstract] [Full Text]  
• Brinkmann, M. M., Schulz, T. F. (2006). Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae.. J. Gen. Virol. 87: 1047-1074 [Abstract] [Full Text]  
• Ingham, R. J., Raaijmakers, J., Lim, C. S. H., Mbamalu, G., Gish, G., Chen, F., Matskova, L., Ernberg, I., Winberg, G., Pawson, T. (2005). The Epstein-Barr Virus Protein, Latent Membrane Protein 2A, Co-opts Tyrosine Kinases Used by the T Cell Receptor. J. Biol. Chem. 280: 34133-34142 [Abstract] [Full Text]  
• Swanson-Mungerson, M. A., Caldwell, R. G., Bultema, R., Longnecker, R. (2005). Epstein-Barr Virus LMP2A Alters In Vivo and In Vitro Models of B-Cell Anergy, but Not Deletion, in Response to Autoantigen. J. Virol. 79: 7355-7362 [Abstract] [Full Text]  
• Schaadt, E., Baier, B., Mautner, J., Bornkamm, G. W., Adler, B. (2005). Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation. J. Gen. Virol. 86: 551-559 [Abstract] [Full Text]  
• Morrison, J. A., Raab-Traub, N. (2005). Roles of the ITAM and PY Motifs of Epstein-Barr Virus Latent Membrane Protein 2A in the Inhibition of Epithelial Cell Differentiation and Activation of {beta}-Catenin Signaling. J. Virol. 79: 2375-2382 [Abstract] [Full Text]  
• Katzman, R. B., Longnecker, R. (2004). LMP2A Does Not Require Palmitoylation To Localize to Buoyant Complexes or for Function. J. Virol. 78: 10878-10887 [Abstract] [Full Text]  
• Ikeda, A., Merchant, M., Lev, L., Longnecker, R., Ikeda, M. (2004). Latent Membrane Protein 2A, a Viral B Cell Receptor Homologue, Induces CD5+ B-1 Cell Development. J. Immunol. 172: 5329-5337 [Abstract] [Full Text]  
• Portis, T., Dyck, P., Longnecker, R. (2003). Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma. Blood 102: 4166-4178 [Abstract] [Full Text]  
• Morrison, J. A., Klingelhutz, A. J., Raab-Traub, N. (2003). Epstein-Barr Virus Latent Membrane Protein 2A Activates {beta}-Catenin Signaling in Epithelial Cells. J. Virol. 77: 12276-12284 [Abstract] [Full Text]  
• Swanson-Mungerson, M., Ikeda, M., Lev, L., Longnecker, R., Portis, T. (2003). Identification of latent membrane protein 2A (LMP2A) specific targets for treatment and eradication of Epstein-Barr virus (EBV)-associated diseases. J Antimicrob Chemother 52: 152-154 [Full Text]  
• Portis, T., Longnecker, R. (2002). Epstein-Barr Virus LMP2A Interferes with Global Transcription Factor Regulation When Expressed during B-Lymphocyte Development. J. Virol. 77: 105-114 [Abstract] [Full Text]  
• Chen, S.-Y., Lu, J., Shih, Y.-C., Tsai, C.-H. (2002). Epstein-Barr Virus Latent Membrane Protein 2A Regulates c-Jun Protein through Extracellular Signal-Regulated Kinase. J. Virol. 76: 9556-9561 [Abstract] [Full Text]  
• Speck, P., Ikeda, M., Ikeda, A., Lederman, H. M., Longnecker, R. (2002). Signal Transduction through the B Cell Antigen Receptor Is Normal in Ataxia-Telangiectasia B Lymphocytes. J. Biol. Chem. 277: 4123-4127 [Abstract] [Full Text]  
• Engels, N., Merchant, M., Pappu, R., Chan, A. C., Longnecker, R., Wienands, J. (2001). Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) Employs the SLP-65 Signaling Module. J. Exp. Med. 194: 255-264 [Abstract] [Full Text]  
• Konishi, K., Maruo, S., Kato, H., Takada, K. (2001). Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation. J. Gen. Virol. 82: 1451-1456 [Abstract] [Full Text]  
• Samaniego, F., Pati, S., Karp, J. E., Prakash, O., Bose, D. (2000). Human Herpesvirus 8 K1-Associated Nuclear Factor-kappa B-Dependent Promoter Activity: Role in Kaposi's Sarcoma Inflammation?. J Natl Cancer Inst Monogr 2000: 15-23 [Abstract] [Full Text]  
• Scholle, F., Bendt, K. M., Raab-Traub, N. (2000). Epstein-Barr Virus LMP2A Transforms Epithelial Cells, Inhibits Cell Differentiation, and Activates Akt. J. Virol. 74: 10681-10689 [Abstract] [Full Text]  
• Swart, R., Ruf, I. K., Sample, J., Longnecker, R. (2000). Latent Membrane Protein 2A-Mediated Effects on the Phosphatidylinositol 3-Kinase/Akt Pathway. J. Virol. 74: 10838-10845 [Abstract] [Full Text]  
• Merchant, M., Caldwell, R. G., Longnecker, R. (2000). The LMP2A ITAM Is Essential for Providing B Cells with Development and Survival Signals In Vivo. J. Virol. 74: 9115-9124 [Abstract] [Full Text]  
• Lee, B.-S., Alvarez, X., Ishido, S., Lackner, A. A., Jung, J. U. (2000). Inhibition of Intracellular Transport of B Cell Antigen Receptor Complexes by Kaposi's Sarcoma-associated Herpesvirus K1. J. Exp. Med. 192: 11-22 [Abstract] [Full Text]  
• Alvarez-Barrientos, A., Arroyo, J., Canton, R., Nombela, C., Sanchez-Perez, M. (2000). Applications of Flow Cytometry to Clinical Microbiology. Clin. Microbiol. Rev. 13: 167-195 [Abstract] [Full Text]  
• Damania, B., Choi, J.-K., Jung, J. U. (2000). Signaling Activities of Gammaherpesvirus Membrane Proteins. J. Virol. 74: 1593-1601 [Full Text]  
• Caldwell, R. G., Brown, R. C., Longnecker, R. (2000). Epstein-Barr Virus LMP2A-Induced B-Cell Survival in Two Unique Classes of E{micro}LMP2A Transgenic Mice. J. Virol. 74: 1101-1113 [Abstract] [Full Text]  
• Choi, J.-K., Lee, B.-S., Shim, S. N., Li, M., Jung, J. U. (2000). Identification of the Novel K15 Gene at the Rightmost End of the Kaposi's Sarcoma-Associated Herpesvirus Genome. J. Virol. 74: 436-446 [Abstract] [Full Text]  
• Glenn, M., Rainbow, L., Auradé, F., Davison, A., Schulz, T. F. (1999). Identification of a Spliced Gene from Kaposi's Sarcoma-Associated Herpesvirus Encoding a Protein with Similarities to Latent Membrane Proteins 1 and 2A of Epstein-Barr Virus. J. Virol. 73: 6953-6963 [Abstract] [Full Text]  
• Scholle, F., Longnecker, R., Raab-Traub, N. (1999). Epithelial Cell Adhesion to Extracellular Matrix Proteins Induces Tyrosine Phosphorylation of the Epstein-Barr Virus Latent Membrane Protein 2: a Role for C-Terminal Src Kinase. J. Virol. 73: 4767-4775 [Abstract] [Full Text]  
• Fujiwara, S., Nitadori, Y., Nakamura, H., Nagaishi, T., Ono, Y. (1999). Epstein-Barr Virus (EBV) Nuclear Protein 2-Induced Disruption of EBV Latency in the Burkitt's Lymphoma Cell Line Akata: Analysis by Tetracycline-Regulated Expression. J. Virol. 73: 5214-5219 [Abstract] [Full Text]  
• Lagunoff, M., Majeti, R., Weiss, A., Ganem, D. (1999). Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA 96: 5704-5709 [Abstract] [Full Text]  
• Fruehling, S., Swart, R., Dolwick, K. M., Kremmer, E., Longnecker, R. (1998). Tyrosine 112 of Latent Membrane Protein 2A Is Essential for Protein Tyrosine Kinase Loading and Regulation of Epstein-Barr Virus Latency. J. Virol. 72: 7796-7806 [Abstract] [Full Text]  
• Lee, H., Guo, J., Li, M., Choi, J.-K., DeMaria, M., Rosenzweig, M., Jung, J. U. (1998). Identification of an Immunoreceptor Tyrosine-Based Activation Motif of K1 Transforming Protein of Kaposi's Sarcoma-Associated Herpesvirus. Mol. Cell. Biol. 18: 5219-5228 [Abstract] [Full Text]  
• Duboise, S. M., Lee, H., Guo, J., Choi, J.-K., Czajak, S., Simon, M., Desrosiers, R. C., Jung, J. U. (1998). Mutation of the Lck-Binding Motif of Tip Enhances Lymphoid Cell Activation by Herpesvirus Saimiri. J. Virol. 72: 2607-2614 [Abstract] [Full Text]  
• Khanna, K. K., Yan, J., Watters, D., Hobson, K., Beamish, H., Spring, K., Shiloh, Y., Gatti, R. A., Lavin, M. F. (1997). Defective Signaling through the B Cell Antigen Receptor in Epstein-Barr Virus-transformed Ataxia-Telangiectasia Cells. J. Biol. Chem. 272: 9489-9495 [Abstract] [Full Text]  
• Prang, N. S., Hornef, M. W., Jager, M., Wagner, H. J., Wolf, H., Schwarzmann, F. M. (1997). Lytic Replication of Epstein-Barr Virus in the Peripheral Blood: Analysis of Viral Gene Expression in B Lymphocytes During Infectious Mononucleosis and in the Normal Carrier State. Blood 89: 1665-1677 [Abstract] [Full Text]  
• Chatila, T., Anderson, K. A., Ho, N., Means, A. R. (1996). A Unique Phosphorylation-dependent Mechanism for the Activation of Ca2+/Calmodulin-dependent Protein Kinase Type IV/GR. J. Biol. Chem. 271: 21542-21548 [Abstract] [Full Text]